Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 1;1(1):82-105.
doi: 10.1007/s40674-014-0005-0.

Management of gastrointestinal involvement in scleroderma

Vivek Nagaraja  1 , Zsuzsanna H McMahan  2 , Terri Getzug  1 , Dinesh Khanna  3
Affiliations

Management of gastrointestinal involvement in scleroderma

Vivek Nagaraja et al. Curr Treatm Opt Rheumatol. .

Abstract

Gastrointestinal tract (GIT) commonly affects patients with systemic sclerosis (SSc). The GI involvement is quite heterogeneous varying from asymptomatic disease to significant dysmotility causing complications like malabsorption, weight loss and severe malnutrition. This review focuses on the management of GI involvement in SSc and has been categorized based on the segment of GIT involved. A brief discussion on the role of patient reported outcome measures in SSc-GI involvement has also been incorporated.

Keywords: Gastrointestinal tract; bacterial overgrowth; constipation; diarrhea; dysphagia; gastric antral vascular ectasia; gastroesophageal reflux; gastroparesis; intestinal dysmotility; nutrition; scleroderma; systemic sclerosis.

PubMed Disclaimer

References

    1. Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Seminars in arthritis and rheumatism. 2010;39(4):269–77. - PubMed
    1. Bodukam V, Hays RD, Maranian P, Furst DE, Seibold JR, Impens A, et al. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology. 2011;50(2):330–4. [This reference highlights the burden of GI involvement in patients with SSc.] - PMC - PubMed
    1. Omair MA, Lee P. Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis. The Journal of rheumatology. 2012;39(5):992–6. - PubMed
    1. Butt S, Emmanuel A. Systemic sclerosis and the gut. Expert review of gastroenterology & hepatology. 2013;7(4):331–9. - PubMed
    1. Jaovisidha K, Csuka ME, Almagro UA, Soergel KH. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature. Seminars in arthritis and rheumatism. 2005;34(4):689–702. - PubMed

LinkOut - more resources